Page 2 - Parthap Majumder News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Parthap majumder. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Parthap Majumder Today - Breaking & Trending Today

Scientists Urge Govt to Release Covaxin Phase 3 Trial Data Before Rollout

Scientists Urge Govt to Release Covaxin Phase 3 Trial Data Before Rollout
15/01/2021
A health worker holds a vial of the Covishield vaccine candidate, after it arrived at a hospital in Ahmedabad, January 12, 2021. Photo: PTI.
New Delhi: After the Union health ministry released a statement by 49 doctors and scientists endorsing the safety of the Covishield and Covaxin vaccine candidates, 13 scientists issued an independent statement urging the government and Bharat Biotech to release data from phase 3 clinical trials of Covaxin, ahead of distributing it to frontline workers in the first phase of India’s vaccination drive, set to begin on January 16.
According to ....

Andhra Pradesh , New Delhi , West Bengal , Tamil Nadu , Vinodk Paul , Rahul Siddharthan , Dipankar Chatterji , Sohan Prabhakar Modak , Analabha Basu , Parthap Majumder , Deepak Kumar Saini , Narinder Mehra , Upendra Nongthomba , Narendra Modi , Gopal Pande , Astrazeneca Covishield , Rajesh Bhushan , Jyotsna Dhawan , Indian Institute Of Science , Indian Academy Of Sciences , Indian Council Of Medical Research , Kalyani Indian Statistical Institute , Covishield Serum Institute , Institute For Mathematical Sciences , Centre For Cellular , Serum Institute ,

Scientists divided over restricted use approval for Covaxin

Coronavirus | Indian scientists divided over nod for Covaxin
Updated:
Updated:
While some say safety parameters are good, others have asked for efficacy data
Share Article
AAA
Medical staff busy in last minute revision for vaccination at jumbo COVID-19 vaccination centre at Bandra-Kurla complex in Mumbai on the eve of first phase vaccination drive. | Photo Credit: Vivek Bendre
While some say safety parameters are good, others have asked for efficacy data
While 3,000 sites across India prepare to vaccinate three crore high-risk individuals, beginning with healthcare workers, from January 16, scientists and doctors are divided on the issue of restricted use approval granted to the Hyderabad-based Bharat Biotech’s Covaxin, a COVID-19 vaccine. ....

South Africa , Tamil Nadu , United Kingdom , New Delhi , Gautam Menon , Sunil Kumar Arora , Gagandeep Kang , Parthap Majumder , Head Of The Epidemiology Division , Union Territories , National Task Force , National Institute Of Biomedical Genomics , Indian Council Of Medical Research , Ashoka University , Health Ministry , Hyderabad Based Bharat Biotech , National Institute , Biomedical Genomics , Aniket Sule , Homi Bhabha Centre , Science Education , Tata Institute , Fundamental Research , Samiran Panda , Epidemiology Division , Indian Council ,